Jubilant Ingrevia Ltd

Jubilant Ingrevia Ltd

$JUBLINGREASpecialty ChemicalsNSEBSE

Jubilant Ingrevia Ltd (JUBLINGREA) last traded at ₹706, a market capitalisation of ₹11,237 crore, on a P/E of 35.3. Over the past 52 weeks the stock has ranged between ₹535 and ₹795. Jubilant Ingrevia Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,300 crore and net profit of ₹106 crore. Figures are as of 25 Aug 2026 and are not real time.

Jubilant Ingrevia Ltd share price and key metrics

Current price
₹706
Market cap
₹11,237 cr
Stock P/E
35.3
Book value
₹196
ROE
9.52%
ROCE
11.4%
Dividend yield
0.70%
52w high / low
795/535

Metrics as of 25 Aug 2026. Not real time.

Jubilant Ingrevia Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹1,300 cr, up 25.2% from ₹1,038 cr a year earlier. Net profit was ₹106 cr, up 41.3% year on year.

Jubilant Ingrevia Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,0451,0571,0511,0381,1211,0511,1791,300
Expenses9219189058969859241,0161,101
Operating profit124138147142135126163199
OPM %12%13%14%14%12%12%14%15%
Other income10981111-4910
Interest1512141312121217
Depreciation4040394141454851
Profit before tax80961021009365112141
Tax %26%27%27%25%25%28%23%25%
Net profit59697475694786106
EPS (₹)3.704.364.654.714.362.945.436.64

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Jubilant Ingrevia Ltd annual results

Jubilant Ingrevia Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6844,9494,7734,1364,1784,3884,651
Operating profit117841549427519568624
OPM %17%17%11%10%12%13%13%
Net profit54477308183251278309
EPS (₹)3.4129.9319.3111.4815.7717.4519.37

TTM is the trailing twelve months to the most recent quarter.

Jubilant Ingrevia Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
45%
3 Years
-3%
TTM
11%
Compounded Profit Growth
10 Years
%
5 Years
35%
3 Years
-2%
TTM
15%
Stock Price CAGR
10 Years
%
5 Years
0%
3 Years
13%
1 Year
-2%
Return on Equity
10 Years
%
5 Years
11%
3 Years
8%
Last Year
10%

Jubilant Ingrevia Ltd shareholding pattern

Promoters held 45.22% at Jun 2026, broadly unchanged since Jun 2025. FIIs 6.49% and DIIs 24.98%.

Jubilant Ingrevia Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters51.47%51.47%51.47%45.22%45.22%45.22%45.22%45.22%
FIIs7.22%6.89%7.12%6.96%5.96%6.15%6.49%6.49%
DIIs15.47%15.99%15.91%21.81%23.04%24.00%24.76%24.98%
Government0.00%0.00%0.00%0.00%0.02%0.02%0.02%0.02%
Public25.09%24.90%24.76%25.30%24.94%23.80%22.53%22.30%
No. of shareholders1,25,3671,24,8301,20,4061,23,7481,25,7491,17,5291,12,6961,10,949

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Jubilant Ingrevia Ltd corporate filings

  • Press ReleaseCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Jubilant Ingrevia Ltd has submitted a press release under Regulation 30 of the SEBI…

    Read the full analysis
  • The Board approved to enter into binding term sheet with Zettaone Technologies India Private Limited (Zettaone) for acquisition of 40% strategic equity stake in Zettaone.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Jubilant Ingrevia Limited has entered into a binding agreement to acquire a 40% strategic…

    Read the full analysis
  • Management of the Company is participating in the Equirus Annual India Conference 2026 on 13th & 14th August, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Jubilant Ingrevia Ltd. announced that its management will participate in the Equirus…

    Read the full analysis
  • Management of the Company is participating in the Nuvama India Conference 2026 on 11th & 12th August, 2026Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Jubilant Ingrevia Ltd. announced that its management will participate in the Nuvama India…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Jubilant Ingrevia Ltd

Cruxal reads every Jubilant Ingrevia Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.